Scancell Holdings PLC banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United Kingdom UK
Employees
60
IPO date
Jul 30, 2010

Scancell Holdings is a UK biotechnology company focused on making new cancer treatments, especially immunotherapies that help the body’s immune system find and attack tumors. Its main work is developing drug candidates in the lab and through clinical trials rather than selling finished medicines today. The company is built around a small number of proprietary platforms, including programs aimed at cancer and some infectious disease targets.

Scancell’s customers are not patients in the usual retail sense. Its main business relationships are with hospitals and trial sites that run studies, research partners, and larger pharmaceutical companies that may license or collaborate on its science. It makes money mainly through research funding, collaboration income, and any future licensing or commercialization deals if its drug candidates are approved and adopted.

What makes Scancell different is that it sits very early in the drug value chain: it is a research-driven developer that creates immune-based therapies and then tries to prove they work well enough to partner with a bigger drug maker or bring them to market. That means the company’s value depends on turning scientific ideas into medicines, not on manufacturing and selling large volumes of products itself.

Scancell Holdings PLC Investor Relations

Address
Unit 202 Bellhouse Building, Sanders Road, Oxford Science Park
Oxford, Oxfordshire
United Kingdom

Business Segments

Cancer immunotherapies

Scancell develops treatments that train the immune system to attack cancer, including vaccine and T-cell based drug candidates in its pipeline.

Customers and revenue model

Antibody platforms

Scancell also builds antibody-based discovery platforms that find and design antibodies for cancer targets.

Customers and revenue model

Management

Prof. Lindy Gillian Durrant Ph.D.

Chief Scientific Officer & Director and Founder

Biography unavailable

Mr. Sathijeevan Nirmalananthan

CFO, Company Secretary & Director

Biography unavailable

Dr. Phillip John L'Huillier

CEO & Director

Biography unavailable

Dr. Samantha Paston Ph.D.

Head of Translational Research

Biography unavailable

Dr. Adrian Parry Ph.D.

Head of Manufacturing

Biography unavailable

Dr. Mandeep Sehmi

Head of Business Development

Biography unavailable

Dr. Callum Scotthasbeen

Head of Development

Biography unavailable

Mr. Alex Hayward

Head of Finance

Biography unavailable

Dr. Nermeen Varawalla DPhil, M.B.A., M.D., MBA, Ph.D.

Chief Medical Officer

Biography unavailable

1 / 9